Yahoo Finance • 11 days ago
In this article, we will be taking a look at the 13 Most Oversold Healthcare Stocks So Far in 2025. Bio-Rad Laboratories, Inc. stands amongst them. Bio-Rad Laboratories, Inc. (NYSE:BIO), a global leader in life science research and clinic... Full story
Yahoo Finance • 13 days ago
NEW YORK, Sept. 15, 2025 /PRNewswire/ -- Fred Alger Management, LLC ("Alger"), a privately held growth equity investment manager, today announced the quarterly rebalancing of the Alger Russell Innovation Index ("Index"). Following the clos... Full story
Yahoo Finance • 27 days ago
Prosper Stars & Stripes, a long/short equity fund, recently released its second quarter 2025 investor letter. A copy of the letter can be downloaded here. The fund underperformed and generated a net return of +9.6% compared to a total retu... Full story
Yahoo Finance • last month
Custom Market Insights [220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Biologics and Biosimilars Market size & share revenue was valued at approximately US... Full story
Yahoo Finance • last month
Chicago, Aug. 19, 2025 (GLOBE NEWSWIRE) -- The Saudi Arabia food safety testing market was valued at US$ 347.13 million in 2024 and is expected to reach US$ 598.44 million by 2033, growing at a CAGR of 6.24% during the forecast period 20... Full story
Yahoo Finance • last month
Delray Beach, FL, Aug. 19, 2025 (GLOBE NEWSWIRE) -- According to research report published by MarketsandMarkets, The globalpostbiotics market is on an impressive upward trajectory, projected to increase from USD 146.7 million in 2025 to... Full story
Yahoo Finance • last month
PANAMA CITY, Aug. 18, 2025 (GLOBE NEWSWIRE) -- HTX, a leading global crypto exchange, saw several newly listed assets deliver outsized gains over the past week (Aug 4–11), accompanied by a sharp surge in trading activity. The broader cry... Full story
Yahoo Finance • 2 months ago
Company Logo The Mexico Microcarrier Market is poised for significant growth, projected to reach US$ 77.65 million by 2033 from US$ 39.96 million in 2024, achieving a CAGR of 7.66% from 2025 to 2033. Key drivers include increased investme... Full story
Yahoo Finance • 2 months ago
Company Logo The global renal transplant therapeutics market, valued at USD 11.35 billion in 2024, is projected to grow at a CAGR of 6.29% till 2032, reaching USD 18.39 billion. Factors driving growth include the rising number of kidney t... Full story
Yahoo Finance • 2 months ago
Bio-Rad Laboratories' (NYSE:BIO) stock is up by a considerable 20% over the past three months. However, we decided to pay attention to the company's fundamentals which don't appear to give a clear sign about the company's financial health.... Full story
Yahoo Finance • 2 months ago
Bio-Rad Laboratories (NYSE:BIO) Second Quarter 2025 Results Key Financial Results Revenue: US$651.6m (up 2.1% from 2Q 2024). Net income: US$317.8m (up from US$2.17b loss in 2Q 2024). Profit margin: 49% (up from net loss in 2Q 2024). EPS:... Full story
Yahoo Finance • 2 months ago
Revenue: $94 billion, up 10% year over year, a June quarter record. Earnings Per Share (EPS): $1.57, up 12% year over year, a June quarter record. iPhone Revenue: $44.6 billion, up 13% year over year. Mac Revenue: $8 billion, up 15% year o... Full story
Yahoo Finance • 2 months ago
Bio-Rad Laboratories Inc. reported a strong performance in the second quarter of 2025, with earnings per share (EPS) of $2.61, surpassing the forecast of $1.73 by 50.87%. Revenue for the quarter reached $651.6 million, exceeding expectatio... Full story
Yahoo Finance • 2 months ago
As the regular session of the US market concludes on Thursday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses. [postmarket] TODAY'S AFTER HOURS GAINERS TICKER... Full story
Yahoo Finance • 2 months ago
Company Logo The North America Autoimmune Disease Diagnostics Market is projected to grow from USD 1.96 billion in 2024 to USD 3.5 billion by 2033, at a CAGR of 6.66%. Key growth drivers include rising incidence of autoimmune conditions l... Full story
Yahoo Finance • 2 months ago
Company Logo The Human Papillomavirus (HPV) Testing Market is projected to grow from USD 1.52 billion in 2024 to USD 3.62 billion by 2033, at a 10.11% CAGR from 2025. This growth is fueled by increased cervical cancer awareness, robust sc... Full story
Yahoo Finance • 2 months ago
We recently compiled a list of 10 Most Undervalued Healthcare Stocks to Buy According to Analysts. Bio-Rad Laboratories, Inc. stands tenth on our list and is currently making waves for launching a new digital PCR system. Bio-Rad Laborator... Full story
Yahoo Finance • 2 months ago
Company Logo Saudi Arabia's in-vitro diagnostics market is set to grow from USD 734.7M in 2024 to USD 932.3M by 2030, driven by a rising elderly population and chronic disease prevalence. Saudi Arabia leads the GCC region in IVD, benefiti... Full story
Yahoo Finance • 3 months ago
HERCULES, Calif. - Bio-Rad Laboratories, Inc. (NYSE:BIO and BIO.B), a life sciences company with a market capitalization of $6.8 billion and strong financial health according to InvestingPro data, announced Monday the launch of four new Dr... Full story
Yahoo Finance • 3 months ago
HERCULES, Calif., July 07, 2025--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced the launch of four new Droplet Digital™ PCR (dd... Full story